Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
3+ week, 2+ day ago (604+ words) combination with Libtayo as a first-line treatment for metastatic or locally advanced melanoma (the "Study...The Study's primary endpoint was progression-free survival ("PFS") and Regeneron has characterized the...
AC/GC School Board Approves Second Reading of Policies
3+ week, 1+ day ago (209+ words) School Boards Policy Primer 34th update and the annual policy review, as well as the 2024-25 audit report..., and 2026-27 certified and classified staff, and student handbooks....
REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt
3+ week, 3+ day ago (684+ words) This Regeneron analyst reaction focuses on analysts' reassessment of the Phase III Fianlimab-Libtayo Study...a prolonged slowdown in progression-free survival event accrual in the Phase III Fianlimab-Libtayo Study...Analysts allegedly reacted to that disclosure as a meaningful change in the…...
MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law
6+ day, 5+ hour ago (175+ words) s first quarter earnings call, defendants allegedly disclosed that the Phase III Fianlimab-Libtayo Study...had been altered, expanding the number of patients in the study eligible for “analysis of progression-free...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
1+ mon, 1+ week ago (375+ words) Raise On December 3, 2025 Capricor announced "Positive Topline Results from Pivotal Phase 3 HOPE-3 Study...Stock Collapse In contrast to Capricor's December claims, the FDA said in the brief that the HOPE-3 study...
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
1+ week, 2+ day ago (290+ words) As a result, the FDA stated that it "considers [Capricor's] analyses based on the post-study SAP versions...
West Carroll School Board Administers Oath of Office, Approves Policy???
6+ day, 16+ hour ago (820+ words) During the administrative reports, district officials highlighted recent successes and ongoing challenges...The high school reported meeting its achievement and growth goals....
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
4+ day, 20+ hour ago (330+ words) Advisory Committee meeting and includes 24-month open-label extension data from the Phase 3 HOPE-3 study...
Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
4+ day, 23+ hour ago (518+ words) for REGN Holders As detailed in the action, Regeneron disclosed on April 29, 2026 that the Phase III study...
HDB Shareholder Alert: HDFC Bank Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
3+ week, 4+ day ago (669+ words) July 17, 2023 — The Class Period Opens on Reported Margins The securities action alleges the Class Period...begins with quarterly results reporting net interest income growth of 21.1% and a core net interest...March 18, 2026 — A Resignation Letter Moves the Stock HDFC Bank reported…...